Old Web
English
Sign In
Acemap
>
Paper
>
Ixazomib-Rituximab in Untreated Indolent B-NHL: An Effective, Very Low Toxicity Regimen
Ixazomib-Rituximab in Untreated Indolent B-NHL: An Effective, Very Low Toxicity Regimen
2020
Solomon A. Graf
Ryan C. Lynch
Ted Gooley
Chaitra S. Ujjani
Peter Wilcox
Sabrina Wilcox
David G. Coffey
Andrew J. Cowan
Stephen D. Smith
Mazyar Shadman
Edus H. Warren
Edward N. Libby
Colin D. Godwin
Ryan D. Cassaday
Jonathan R. Fromm
Ajay K. Gopal
Keywords:
Rituximab
Oncology
Internal medicine
Regimen
Ixazomib
low toxicity
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]